Kau patent opposition analysis

The comprehensive analysis of Kau opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Kau

Patent NumberTitleApplicantOpposition DateOpposition Company
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIM INTERNATIONAL GMBHSep 3, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD
Sglt-2 Inhibitor For Treating Type 1 Diabetes Mellitus, Type 2 Diabete Mellitus, Impaired Glucose Tolerance Or HyperglycemiaBOEHRINGER INGELHEIM INTERNATIONAL GMBHAug 13, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD
Method Of Treating Cancer Using Selective Estrogen Receptor ModulatorsDUKE UNIVERSITYJul 20, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISK A/SApr 19, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD
Starting Dose Of Pth ConjugatesASCENDIS PHARMA BONE DISEASES A/SApr 1, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALS, INC.Mar 10, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD
Methods Of Treating Prostate CancerJANSSEN PHARMACEUTICA NVOct 21, 2025TEVA PHARMACEUTICAL INDUSTRIES LTD
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALS, INC.Jul 16, 2025TEVA PHARMACEUTICAL INDUSTRIES LTD
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSMay 7, 2025TEVA PHARMACEUTICAL INDUSTRIES LTD
Compounds And Methods For Treatment Of Inflammatory Bowel Disease With Extra-Intestinal ManifestationsARENA PHARMACEUTICALSFeb 1, 2025TEVA PHARMACEUTICAL INDUSTRIES LTD